Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pediatr Surg ; 34(1): 9-19, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37567253

ABSTRACT

OBJECTIVE: Intestinal volvulus in the neonate is a surgical emergency caused by either midgut volvulus (MV) with intestinal malrotation or less commonly, by segmental volvulus (SV) without intestinal malrotation. The aim of our study was to investigate if MV and SV can be differentiated by clinical course, intraoperative findings, and postoperative outcomes. METHODS: Using a defined search strategy, two investigators independently identified all studies comparing MV and SV in neonates. PRISMA guidelines were followed, and a meta-analysis was performed using RevMan 5.3. RESULTS: Of 1,026 abstracts screened, 104 full-text articles were analyzed, and 3 comparative studies were selected (112 patients). There were no differences in gestational age (37 vs. 36 weeks), birth weight (2,989 vs. 2,712 g), and age at presentation (6.9 vs. 3.8 days). SV was more commonly associated with abnormal findings on fetal ultrasound (US; 65 vs. 11.6%; p < 0.00001). Preoperatively, SV was more commonly associated with abdominal distension (32 vs. 77%; p < 0.05), whereas MV with a whirlpool sign on ultrasound (57 vs. 3%; p < 0.01). Bilious vomiting had similar incidence in both (88 ± 4% vs. 50 ± 5%). Intraoperatively, SV had a higher incidence of intestinal atresia (2 vs. 19%; p < 0.05) and need for bowel resection (13 vs. 91%; p < 0.00001). There were no differences in postoperative complications (13% MV vs. 14% SV), short bowel syndrome (15% MV vs. 0% SV; data available only from one study), and mortality (12% MV vs. 2% SV). CONCLUSION: Our study highlights the paucity of studies on SV in neonates. Nonetheless, our meta-analysis clearly indicates that SV is an entity on its own with distinct clinical features and intraoperative findings that are different from MV. SV should be considered as one of the differential diagnoses in all term and preterm babies with bilious vomiting after MV was ruled out-especially if abnormal fetal US and abdominal distension is present.


Subject(s)
Digestive System Abnormalities , Intestinal Volvulus , Short Bowel Syndrome , Humans , Infant , Infant, Newborn , Digestive System Abnormalities/complications , Digestive System Abnormalities/diagnostic imaging , Digestive System Abnormalities/surgery , Intestinal Volvulus/diagnostic imaging , Intestinal Volvulus/surgery , Short Bowel Syndrome/complications , Vomiting/complications
2.
Can J Infect Dis Med Microbiol ; 2022: 2659883, 2022.
Article in English | MEDLINE | ID: mdl-35812013

ABSTRACT

The nosocomial spread of Mycobacterium tuberculosis from a healthcare worker with infectious pulmonary tuberculosis disease to patients remains a risk in the healthcare environment, including neonatal intensive care units. In this paper, we outlined a protocol for neonates exposed to tuberculosis in a neonatal intensive care unit that includes skin testing, chest X-ray imaging, and prophylactic isoniazid. Neonatal patients were followed up with tuberculosis skin testing at both three months corrected age and two months postexposure. To our knowledge, this is the first Canadian study to illustrate a protocol following tuberculosis exposure in a neonatal intensive care unit for exposed neonates.

3.
Paediatr Child Health ; 27(4): 195-197, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35859685
4.
Pediatr Infect Dis J ; 41(5): e233-e234, 2022 05 01.
Article in English | MEDLINE | ID: mdl-35213865

ABSTRACT

Severe coronavirus disease 2019 (COVID-19) occurs in approximately 10% of neonates infected with severe acute respiratory syndrome coronavirus 2. Guidelines for optimal management of severe COVID-19 in neonates do not exist. In this report, we describe a late-preterm neonate with severe COVID-19, requiring invasive mechanical ventilation who recovered following treatment with remdesivir and high dose dexamethasone.


Subject(s)
COVID-19 Drug Treatment , Respiratory Insufficiency , Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Humans , Infant , Infant, Newborn , Infant, Premature , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL
...